biosante Pages on BioPortfolio:

BioSante Pharmaceuticals Announces Reacquisition of Elestrin, FDA ...
Pharma Live:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioSante Pharma Announces Its Re-Acquisition of Elestrin
Yahoo!:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioSante gets US FDA SPA for LibiGel for female sexual dysfunction
PharmaBiz:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioSante Pharmaceuticals Announces FDA Special Protocol Assessment ...
Yahoo! Canada:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioSante Pharmaceuticals Announces FDA Special Protocol Assessment ...
Business Wire via Yahoo!:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioSante Pharmaceuticals Announces FDA Special Protocol Assessment ...
Forbes.com:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioSante Pharmaceuticals Announces FDA Special Protocol Assessment ...
Genetic Engineering News:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Results from other life science and pharmaceutical sites:

BioSante Pharmaceuticals, Inc. Announces Reacquisition of Elestrin ...
7 Aug 2008 ... BioSante immediately will assume all manufacturing, distribution and marketing responsibilities for Elestrin. Elestrin is a fast-drying gel ...
http://www.biospace.com/news_story.aspx?NewsEntityId=106088...

BioSpace - BioSante Pharmaceuticals, Inc. News, Search Jobs, Events
BioSante is developing a pipeline of hormone therapy products to treat both men and women. These hormone therapy products are gel formulations for ...
http://www.biospace.com/company_profile.aspx?CompanyId=1592...

BioSante Pharmaceuticals, Inc. Announces FDA Special Protocol ...
“In addition to being another major milestone for BioSante, receiving a second SPA for naturally menopausal women is a significant development for the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=103430...

BioSante Pharmaceuticals, Asta Funding and Perfect World Ltd lead ...
BioSante Pharmaceuticals Inc (NasdaqGM:BPAX - News), Asta Funding Inc (NasdaqGS: ASFI - News) and Perfect World Co Ltd (NasdaqGM:PWRD - News) are among the ...
http://biz.yahoo.com/smallcapinvestor/080613/9425.html?.v=1...

News: BioSante Pharmaceuticals Announces License Agreement for its ...
BioSante Pharmaceuticals Announces License Agreement for its CaP Technology in Aesthetic Medicine. Genetic Engineering & Biotechnology News - Biotechnology ...
http://www.genengnews.com/news/bnitem.aspx?name=26902550...

Summary of BIOSANTE PHARMACEUTICALS INC - Yahoo! Finance
On August 11, 2008, BioSante Pharmaceuticals, Inc. publicly announced its financial results for the second quarter ended June 30, 2008. ...
http://biz.yahoo.com/e/080811/bpax8-k.html...

BioSante Pharmaceuticals, Inc. Receives FDA Approval Of Bio-E-Gel ...
18 Dec 2006 ... BioSante announced the signing of a marketing agreement with Bradley Pharmaceuticals, Inc. (NYSE:BDY - News) on November 8, 2006. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=40366...

Summary of BIOSANTE PHARMACEUTICALS INC - Yahoo! Finance
The following discussion of the results of operations and financial condition of BioSante should be read in conjunction with our financial statements and ...
http://biz.yahoo.com/e/071113/bpax10-q.html...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.